Tech Company Financing Transactions

Garuda Therapeutics Funding Round

Aisling Capital, Cormorant Asset Management and Mass General Brigham Innovation joined a $72 million Series A funding round for Garuda Therapeutics. The round closed on 9/24/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

22 Strathmore Rd.
Natick, MA 01760
USA

Phone

Undisclosed

Website

www.garudatx.com

Email Address

[email protected]

Overview

Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Dhvanit Shah

        

Co-Founder

Sean Morrison

        

Co-Founder

David Scadden

        

Browse more venture capital transactions:

Prev: 9/24/2021: FruitScout venture capital transaction
Next: 9/24/2021: Misfits Gaming venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary